New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls. Read the Q3 2026 report

Tvardi Therapeutics, Inc.

TVRD

Healthcare Biotechnology

Tvardi Therapeutics, Inc.’s revenue for fiscal 2024 (year ended December 2024) was $7.1 million, down 66.0% from fiscal 2023.

Revenue
+20.3%
EPS
n/m
Free cash flow
n/m

Quarter to September 2026, against a year earlier

0.99 0.04 +4.21%

After hours trading: 0.97, down 2.02%, last trade Fri 7:28pm Eastern.

Market cap
$12.6M
P/E
n/m
Fwd P/E FY25e
n/m
Dividend yield
—
F-score
3/9
ROIC
0.00%
Net debt / EBITDA
1.1×
Payout ratio
—

What it owns vs. what it owes End of fiscal 2025, Dec 31, 2025

Debt has risen from $3.4M to $30.3M since FY19. Shareholders’ equity is 65.3% of the balance sheet. What is a balance sheet?

Dec 31, 2025 · total $32.1M

Owns

$535.0KLong-term assets
$727.0KOther short-term assets
$30.8MCash & short-term investments

Funded by

$20.9MShareholders’ equity
$11.1MOther liabilities

Debt is 0.00% of the total; shareholders’ equity 65.3%.

Net cash fell from 65% of assets to 4% since FY19.

Total assetsNet debt (debt less cash)Net debt ÷ assets (right axis)
Assets and net debt, five years
FY19FY20FY21FY22FY24
Total assets$233M$271M$247M$182M$35M
Net debt (debt less cash)−$152M−$177M−$165M−$144M−$1.4M
Net debt ÷ assets (right axis)−65.1%−65.4%−66.8%−79.0%−3.8%
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
Total current assets
61.45 95.06 168.14 165.66 195.07 173.29 168.91 116.16 31.69 31.54
Total non-current assets
2.38 1.95 22.68 67.30 76.09 73.77 13.33 9.69 3.51 0.54
Total Assets
63.83 97.00 190.82 232.96 271.16 247.06 182.24 125.84 35.20 32.07
Total current liabilities
11.53 8.51 40.45 42.89 18.48 17.62 23.46 25.59 10.37 11.04
Total non-current liabilities
1.57 1.72 16.75 3.35 3.67 1.92 — 43.17 115.96 0.09
Total liabilities
13.10 10.22 57.19 46.25 22.16 19.53 23.46 68.76 126.33 11.13
Common Equity (Total)
50.73 86.78 133.63 186.71 249.00 227.52 158.78 57.09 (91.13) 20.95
Shareholders Equity (Total)
50.73 86.78 133.63 186.71 249.00 227.52 158.78 57.09 (91.13) 20.95
Total Debt
— — — 3.35 3.67 1.92 1.92 — 30.26 —

Show all line items

In millions of $ except per-share values · columns are period end dates · fundamentals updated Nov 17, 2026